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Description of Cases
Two pregnant patients (PP) presenting
cutaneous ulcers were referred to our
outpatient clinics at Instituto de Pesquisas
Clı´nicas Evandro Chagas (IPEC)–Fiocruz.
The first patient (PP1, 24 years old) had an
ulcer above the knee (35625 mm). The
second patient (PP2, 25 years old) present-
ed an ulcer (22617 mm) on the left arm.
Lesion onset occurred approximately 2
months earlier in both patients, and both
were 2–3 months pregnant. As they lived
in areas endemic for American cutaneous
leishmaniasis (ATL) and sporotrichosis
(SP), specific tests for ATL and SP (lesion
biopsies: histopathology, immunohisto-
chemistry [IHC], and parasite/fungi/bac-
teria isolation; peripheral blood: serology)
were performed. Routine pregnancy
screenings were done, and blood counts
and biochemistry were within the normal
range.
Diagnosis Confirmation and
Follow-up
The diagnosis for both patients was
localized ATL (LCL), since Leishmania
parasites, characterized as Leishmania
braziliensis, were isolated from lesions,
whereas isolation of fungi and bacteria
(including mycobacteria) was negative.
This was confirmed by histopathology
and IHC. As the patients were pregnant,
specific anti-leishmanial treatment was
not started, and the patients were
monitored monthly. The lesion of PP1
increased in size (50637 mm) and be-
came ulcerative-vegetative at 5 months
of pregnancy, and towards the end of
pregnancy (8–9 months), small satellite
ulcers appeared (not shown) around the
main lesion (54640 mm) (Figure 1 PP1-
A). No other skin or mucosal lesions were
detected. About 2 months after delivery,
the exuberance of the lesions had de-
creased; they became shallower and less
secreting. At 3 months postpartum,
satellite lesions healed, and the beginning
of peripheral epithelialisation with hy-
per-pigmentation areas was observed
(Figure 1 PP1-B). This clinical evidence
of spontaneous improvement after deliv-
ery was confirmed by IHC (Figure 2). An
inflammatory granulomatous infiltrate
with areas of fibrosis and epithelialisation
was detected. Since the patient decided
to continue breastfeeding, treatment with
pentavalent antimony was not started.
Clinical cure occurred 3 months later,
and the lesions remained healed 48
months later without any sign of mucosal
metastasis.
The lesion of PP2 also developed as
ulcerative-vegetative and increased in
size until 6 months of pregnancy
(40626 mm), when the lesion size stabi-
lized (Figure 1 PP2-A). At 2 months
postpartum, the area measured
27620 mm; it was epithelialised and
completely healed 6 months postpartum
(Figure 1 P2-B). At this time, histopa-
thology showed the presence of fibrous
tissue with focal residual inflammatory
cells, and no parasites were detected.
The patient did not receive specific
treatment, and 12 months after delivery,
the area presented an atrophic scar
measuring 26625 mm. No signs of
mucosal lesions were detected, and
Leishmania serology was negative.
Why Do ATL Lesions Tend to
Worsen during Pregnancy?
The changes in innate and adaptive
maternal immune responses during preg-
nancy are tightly linked to gestation and
normalize postpartum [1]. These transient
changes can have both beneficial and
detrimental consequences, as exemplified
by improved rheumatoid arthritis and
systemic lupus erythematosus [2] and
enhanced susceptibility to infection or
aggravated disease during pregnancy [3].
However, understanding of the impact of
parasitic diseases on mother and infant is
still limited.
Some aspects of the maternal immune
response to Leishmania spp during preg-
nancy have been studied in animal models
and showed that Leishmania-infected preg-
nant C57BL/6 mice developed larger
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lesions, harbored increased parasite bur-
dens, and expressed less IFN-c but
increased levels of IL-4, IL-5, and IL-
10 as compared to nonpregnant controls
[4,5]. In this model, IFN-c and TNF-a
production by placental cells correlated
with fetal resorption and implantation
failure [6]. These data suggest that anti-
leishmanial Th1 responses could ad-
versely affect the success of pregnancies,
either by interfering with placental de-
velopment and maintenance and/or by
impairing preimplantation events. These
results imply that the modulation of
maternal immune responses during preg-
nancy favors parasite growth and lesion
development. Furthermore, control of
Leishmania panamensis infection during
pregnancy in a hamster model was
mostly due to innate immune responses,
including enhanced estrogen-mediated
up-regulation of NOS2 expression and
NO production [7].
Human pregnancy has been associat-
ed with a shift in Th1/Th2 balance,
and pregnant woman exhibit reduced
type 1 responsiveness, which is consid-
ered to be important for healing in
leishmaniasis. Indeed, atypical manifes-
tations and worsening of LCL during
pregnancy is consistent with this inter-
pretation, but the mechanism is not
fully characterized.
Can We Detect Changes in
Immune Responses of Pregnant
ATL Patients?
To answer this question, we tested local
(lesion) and systemic (blood) immune
responses. Punch biopsies from cutaneous
lesion (5–6 mm) and/or peripheral blood
samples (EDTA) were collected in the
second, fifth, and eighth month of preg-
nancy and 2–6 months after delivery. We
also tested tissue and blood from six
nonpregnant, age-matched ATL patients
before treatment (Table S1), as well as
peripheral blood of ten healthy, age-
matched female volunteers (25.560.93
years).
This study was approved by the Ethics
Committee in Human Research (CEP–
IPEC–Fiocruz–number 014/2001). All
participants gave written informed con-
sent.
The in situ inflammation was evaluated
by IHC as described [8] at the eighth
month of pregnancy and at 2–6 months
postpartum as well as in the nonpregnant
ATL group before treatment (Figure 2,
Table S2). Despite similarities in organi-
zation and architecture of the inflamma-
tory site during pregnancy and after birth,
the concentration and distribution of some
cell types and secretory products changed
in both pregnant patients after delivery. T
lymphocytes and macrophages were abun-
dant at both times (Figure 2A–2D).
Postpartum, a pronounced increase in
both extent and number of NOS2 positive
areas was detected (Figure 2E–2F). In
accordance with increased NOS2, para-
sites were no longer detectable in the
lesion postpartum (Figure 3 upper panel).
Although the distribution of IL-10 positive
areas remained similar on two occasions
(Figure 2I–2J), there was an increase of
IFN-c positive areas postpartum
(Figure 2G–2H). At the same time, an
increase in the percentage of B cells,
neutrophils, Bax+ cells, CD25+, and
Foxp3+ cells was observed. However,
Bcl-2+ and Ki-67+ cells were reduced. In
the eighth month of pregnancy, the
patients expressed less IFN-c than non-
pregnant female ATL patients (Table S2).
The enzymatic activity of arginase
present in serum was measured as previ-
ously described [9]. The enzyme arginase,
chiefly expressed in human neutrophils
and macrophages, catabolizes its substrate
L-arginine, and under certain conditions,
increased arginase activity causes reduc-
tion in L-arginine levels in the extracellu-
lar fluid. Reduced availability of L-argi-
nine can impair T cell responses and
weaken immune responses against infec-
tion [10]. We previously reported en-
hanced arginase activity in pregnant
women and wished to test the hypothesis
that worsening of leishmaniasis in preg-
nancy is associated with increased arginase
activity [9]. Results presented in Figure 3
(lower panel) show that in both pregnant
patients, arginase activity increased during
pregnancy and declined at time of birth to
levels similar to those observed in ATL
nonpregnant controls.
Antigen-specific cytokine secretion by
PBMC was assessed by ELISPOT assay at
8 months of pregnancy and 2–6 months
after birth, as well as in nonpregnant ATL
patients before treatment and in healthy
volunteers. IFN-c secretion was decreased
in both patients during pregnancy but
increased postpartum, reaching values
comparable to those seen in untreated
nonpregnant ATL patients (Figure 4A).
Furthermore, high frequencies of IL-10–
producing cells were detected in the
absence of antigen that decreased follow-
ing antigenic restimulation in ATL pa-
tients and in ATL pregnant patients after
birth. However, antigen-specific IL-10–
producing cells increased in response to
specific restimulation during pregnancy
(Figure 4B). Thus, the results obtained
from lesion tissues and peripheral blood
show changes in both local and systemic
maternal immune responses. After deliv-
Figure 1. Cutaneous lesions in ATL patients during pregnancy and post delivery. The
upper left picture shows the lesion of pregnant patient 1 (PP1-A) at 8 months of pregnancy, and
the upper right shows the lesion of the same patient 3 months after birth (PP1-B). The lower left
picture shows the lesion of pregnant patient 2 (PP2-A) at 6 months of pregnancy, and the lower
right picture shows the lesion of this ATL patient 6 months post delivery (PP2-B). Lesions during
pregnancy developed as ulcerative-vegetative (A), and post delivery, signs of lesion healing
(epithelialisation, hyperpigmentation, and fibrosis) are seen (B).
doi:10.1371/journal.pntd.0002472.g001
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ery, the healing of lesions correlated with
increased in situ NOS2 expression
(Figure 2F), decreased parasite counts
(Figure 3 upper panel), as well as increased
systemic and in situ expression of IFN-c
(Figure 4A).
Should ATL Be Treated during
Pregnancy?
Studies on different maternal infections
have shown that mother and offspring can
have distinct susceptibilities to infection in
each stage of reproduction, from concep-
tion and gestation to parturition and the
neonatal period. With regard to infections
with protozoans, maternal malaria has
been associated with fetal infection, pre-
term delivery, and growth restriction as
well as maternal per partum death due to
hemorrhagic complications [3]. The im-
pact of the time of gestation on the
consequences of infection was shown in
toxoplasmosis: severe congenital toxoplas-
mosis was associated with maternal
infection starting in the second trimester
of pregnancy, and infections in the first
trimester were associated with fetal loss
due to severe damage to the embryo
[11]. To our knowledge, there are no
publications addressing these issues in
cutaneous leishmaniasis (CL) patients.
Untreated visceral leishmaniasis (VL)
during pregnancy puts maternal life at
risk and may result in fetal loss or in
congenital VL [12,13], and therefore,
treatment of VL during pregnancy is
compulsory. However, treatment of
pregnant ATL patients is a debated issue
[12,14,15] since there is no description of
congenital infection, and many antileish-
manial drugs, such as pentavalent anti-
mony or miltefosine, are teratogenic [15–
18]. Consequently, alternative therapies
should be evaluated in order to warrant
safety and efficacy in this group of
patients. Guimara˜es et al [19] showed
that 40% of patients with atypical
manifestation of ATL were pregnant
women and suggested that Amphotericin
B should be considered as the drug of
choice for all patients diagnosed with
atypical ATL. Intralesional treatment
with meglumine antimoniate was suc-
cessful in over 83% of patients treated
who had contraindication to systemic
therapy [20], but there is a lack of
evidence demonstrating safety in preg-
nant women. As spontaneous healing has
been reported to occur after delivery
[21], several groups avoid the use of
specific treatment and follow the patients
by using local heating and/or antibiotic
ointments to control lesion development
and secondary infections. More work is
required to optimize the management of
ATL during pregnancy.
Is the Occurrence of Metastases
Possible?
The mechanism of metastasis in ATL is
not fully understood. In Brazil, 3–5% of
patients with LCL caused by L. braziliensis
can develop mucosal lesions. Some of
these patients did not have treatment
during the primary infection, but metas-
tasis can also occur after appropriate
treatment [22]. We have followed up with
our two pregnant ATL patients for 3–4
years, and they did not relapse or show
any signs of mucosal lesions.
Figure 2. Inflammatory reaction in active cutaneous lesions of untreated ATL patient (PP1) during pregnancy and postpartum. The
inflammatory response in the lesions was assessed by in situ immunohistochemistry. (A,B) CD8+ cells, (C,D) CD68+ cells, (E,F) NOS2, (G,H) IFN-c, and
(I,J) IL-10 expression in active lesions of pregnant ATL patient (PP1). (A,C,E,G,I) at 8 months of pregnancy; (B,D,F,H,J) at 2–6 months post delivery;
Magnification: 2006 (bar = 50 mm); arrows indicate examples of positive areas.
doi:10.1371/journal.pntd.0002472.g002
Figure 3. (Upper panel) Parasite enumeration during pregnancy and postpartum.
Amastigotes present in the lesions were enumerated by in situ immunohistochemistry in active
cutaneous lesions of both pregnant patients (PP1, PP2) before treatment, in the eighth month of
pregnancy (gray bars) and 2–6 months after birth (black bars). Amastigote numbers present in
lesions of nonpregnant ATL patients (average of three patients) before treatment are shown as
comparison. The results are expressed as number of parasites per mm2, using a grid-scale
consisting of 20620 subdivisions in an area of 10 mm2610 mm2, adapted to slides as previously
described [24]. The results shown are median 6 SEM. n.d. = not detectable; (Lower panel) Serum
arginase activity. Arginase activity (U/mL) was determined in sera obtained from peripheral blood
of pregnant ATL patients collected at 3, 5, and 9 months of pregnancy (black bar PP1; grey bar
PP2) as well as four age-matched nonpregnant ATL patients (hatched bars). The results shown are
median 6 SEM.
doi:10.1371/journal.pntd.0002472.g003
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Discussion
Exacerbation of cutaneous lesions in
pregnant women due to infection with
new- and old-world Leishmania spp has
been reported; however, the mechanisms
accounting for exacerbation of CL have
not been clarified [4,16,19,23]. Our results
show transient modulation of maternal
immune responses during pregnancy as
indicated by exacerbated cutaneous le-
sions, increased parasite burdens, and
decreased levels of IFN-c and NOS2. Of
note, both pregnant ATL patients had a
restored Th1 response postpartum, asso-
ciated with healing of the lesions. CL
represents the majority of leishmaniasis
cases worldwide, and in Brazil, 36% of the
infected individuals are women of child-
bearing age [22]. Despite the fact that our
study was conducted in an endemic area,
during an observation period of 4 years,
only three pregnant women presented to
our clinic with CL, and one of them had
an abortion unrelated to leishmaniasis.
The impact of pathogens on human
reproduction could be mitigated or exac-
erbated depending on the time of
infection during pregnancy, the maternal
immune response, nutritional status, and
Figure 4. Determination of IFN-c and IL-10–producing cells in the peripheral blood during pregnancy and postpartum. (A) The
number of IFN-c and (B) of IL-10–producing cells in peripheral blood was determined at 8 months of pregnancy and 2–6 months after birth in both
pregnant ATL patients by ELISPOT assay and compared to those present in nonpregnant ATL patients before specific treatment and in healthy
volunteers. Spontaneous release (black bars) as well as antigen-specific responses to restimulation with Leishmania-antigen in vitro (grey bars) are
shown. The results from antigen-stimulated PBMC were expressed as the difference of the number of spots/10,000 PBMC in the antigen-stimulated
wells minus the mean number of spots in control wells (with medium alone= spontaneous release) from the same donor. The results shown are
median 6 SEM.
doi:10.1371/journal.pntd.0002472.g004
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co-morbidities as described in toxoplas-
mosis [3]. The number of pregnant
women infected with Leishmania parasites
is generally low, and no information about
the frequency of fetal loss in ATL patients
is currently available.
At present, it is unclear whether the
scarcity of reports on leishmaniasis in
pregnancy is due to the use of contracep-
tives during the antimonial treatment, to
increased embryo resorption or fetal
abortion, to exclusion of pregnant women
in many study designs, or to insufficient
data on epidemiology of pregnant women
suffering from leishmaniasis, a complex of
diseases belonging to the most neglected
tropical diseases.
Supporting Information
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Key Learning Points
N Pregnancy is accompanied by transient changes of maternal immunity,
exemplified by decreased Th1- and increased Th2-type responses. The changes
in innate and adaptive maternal immune responses during pregnancy are
tightly linked to gestation and normalize postpartum.
N In patients with leishmaniasis, these transient changes in the maternal immune
system enhance susceptibility to infection with Leishmania parasites and result
in aggravated disease during pregnancy.
N Several drugs used to treat leishmaniasis are teratogenic. But if treatment is
necessary, literature points to Amphotericin B as the drug of choice.
N Treatment of visceral leishmaniasis during pregnancy is compulsory, since
vertical transmission has been demonstrated.
N As vertical transmission has not been described in cutaneous/mucosal
leishmaniasis, patients with ATL may not be treated if the lesions are contained
but should be frequently monitored during the course of pregnancy and
postpartum.
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